CRISPR-Cas9 editing was utilized to knock down TRIM32 in C2C12 cells (Fig. 2I through K), and a moderate recovery of infection was detected in the TRIM32-deficient cells (Fig. 2J and K). Here, TRIM32 is linked to infection.